PDE5 inhibitors in non-urological conditions

C Vlachopoulos, D Terentes-Printzios… - Current …, 2009 - ingentaconnect.com
Phosphodiesterase type-5 (PDE5) inhibitors are widely used as first-line therapy for erectile
dysfunction (ED). Their efficacy and safety combined with an increasing understanding of …
被引用次数：41 相关文章

PDE5 inhibitors in non-urological conditions.

C Vlachopoulos, D Terentes-Printzios… - Current …, 2009 - europepmc.org
Phosphodiesterase type-5 (PDE5) inhibitors are widely used as first-line therapy for erectile
dysfunction (ED). Their efficacy and safety combined with an increasing understanding of …

[引用][C] PDE5 Inhibitors in Non-Urological Conditions: Phosphodieterase-5 Inhibitors and their Use in the Treatment of Urological Conditions

C VLACHOPOULOS… - Current …, 2009 - pascal-francis.inist.fr
PDE5 Inhibitors in Non-Urological Conditions : Phosphodieterase-5 Inhibitors and their Use
in the Treatment of Urological Conditions CNRS Inist Pascal-Francis CNRS Pascal and …

PDE5 inhibitors in non-urological conditions

C Vlachopoulos… - Current …, 2009 - pubmed.ncbi.nlm.nih.gov
Phosphodiesterase type-5 (PDE5) inhibitors are widely used as first-line therapy for erectile
dysfunction (ED). Their efficacy and safety combined with an increasing understanding of …

PDE5 inhibitors in non-urological conditions

C Vlachopoulos, D Terentes-Printzios… - Current …, 2009 - hero.epa.gov
Abstract Phosphodiesterase type-5 (PDE5) inhibitors are widely used as first-line therapy for
erectile dysfunction (ED). Their efficacy and safety combined with an increasing …

[引用][C] PDE5 Inhibitors in Non-Urological Conditions

C VLACHOPOULOS, D TERENTES-PRINTZIOS… - Current pharmaceutical …, 2009 - Bentham